Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research overview-2025: integrating scientific progress to accelerate global tuberculosis elimination.

Frontiers in tuberculosis·2026
Same author

An Innovative Model for Graduate Medical Education Faculty Development Through Physician-in-Training Delivery.

HCA healthcare journal of medicine·2026
Same author

Evaluating Tuberculosis Surveillance Using Global Standards and Benchmarks in the Philippines: Mixed Methods Study.

JMIR public health and surveillance·2026
Same author

Using genomic epidemiology and geographic activity spaces to investigate tuberculosis outbreaks in Botswana.

International journal of health geographics·2026
Same author

Tuberculosis Cases and Deaths Averted by PEPFAR.

The New England journal of medicine·2026
Same author

Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020-2024.

Emerging infectious diseases·2026

Related Experiment Video

Updated: Jun 5, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

Patrick K Moonan1, Teresa N Quitugua, Janice M Pogoda

  • 1University of North Texas Health Science Center at Fort Worth, Department of Medicine, USA.

BMC Public Health
|January 11, 2011
PubMed
Summary

Universal directly observed therapy (DOT) for tuberculosis significantly reduces the acquisition and transmission of drug-resistant strains. This strategy is crucial for effective tuberculosis control and preventing the spread of resistant TB.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Related Experiment Videos

Last Updated: Jun 5, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Microbiology

Background:

  • Directly Observed Therapy (DOT) is recommended for tuberculosis (TB) management, but its impact on drug-resistant TB transmission is debated.
  • This study investigates the role of DOT practices in the transmission of drug-resistant TB genotypes.

Purpose of the Study:

  • To compare drug-resistant genotype cluster proportions between communities with universal DOT and selective DOT.
  • To assess the impact of DOT strategies on the acquisition and transmission of drug-resistant tuberculosis.

Main Methods:

  • Genotyping of 1,706 tuberculosis isolates (1995-2001) using IS6110 RFLP and spoligotyping to define genotype clusters.
  • Logistic regression analysis to compare drug resistance prevalence in cluster members between universal and selective DOT settings.

Main Results:

  • Isolates from selective DOT counties were more than twice as likely to be drug-resistant (OR = 2.3) compared to universal DOT counties.
  • Selective DOT was associated with nearly 5 times higher odds of belonging to clusters with multiple resistant isolates (OR = 4.7).

Conclusions:

  • Universal DOT implementation is linked to a reduction in the acquisition and transmission of drug-resistant tuberculosis.
  • Findings support universal DOT as a key strategy for controlling drug-resistant TB.